Kardiomiopati Dilatasi pada Pasien HIV-AIDS

Sidhi Laksono Purwowiyoto

Abstract


The heart and great vessels are not the sites most frequently affected by opportunistic infections and neoplastic processes in patients with acquired immune deficiency syndrome (AIDS). HIV-related disease is now recognized as an important cause of dilated cardiomyopathy, with a prevalence of 8%–30%. Patients with HIV-infection and dilated cardiomyopathy have a much worse prognosis than those with idiopathic dilated cardiomyopathy. Cardiac involvement in HIV represents a pathophysiologic, diagnostic and therapeutic challenge for cardiologists. This review describes pathophysiology, diagnosis, treatment and prognosis of HIV- dilated cardiomyopathy.


Keywords


HIV-AIDS, dilated cardiomyopathy, pathophysiology, diagnosis, treatment, prognosis

Full Text:

PDF (Indonesian)

References


Fisher SD, Lipshultz SE. Cardiovascular Abnormalities in HIV-Infected Individuals. In: Robert O Bonow DLM, Douglas P Zipes, Peter Libby, ed. Braundwald's Heart Disease A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia: Elsevier Saunders; 2012:1618-21.

Baralkiewicz G, Mularek-Kubzdela T, Juszczyk J, Cieslinski A. [Dilated cardiomyopathy in HIV infection]. Pol Merkur Lekarski 2000;9:565-7.

Hare JM. The Dilated, Restrictive, and Infiltrative Cardiomyopaties. In: Robert O Bonow DLM, Douglas P Zipes, Peter Libby, ed. Braundwald's Heart Disease A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia: Elsevier Saunder; 2012:1561-71.

Currie PF, Boon NA. Immunopathogenesis of HIV-related heart muscle disease: current perspectives. AIDS 2003;17 Suppl 1:S21-8.

Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol 1989;13:1030-6.

Levy WS, Simon GL, Rios JC, Ross AM. Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol 1989;63:86-9.

Barbaro G. Cardiovascular manifestations of HIV infection. J R Soc Med 2001;94:384-90.

Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA. Heart muscle disease related to HIV infection: prognostic implications. BMJ 1994;309:1605-7.

Lipshultz SE, Easley KA, Orav EJ, et al. Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation 2000;102:1542-8.

Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 1998;339:1093-9.

Kearney DL, Perez-Atayde AR, Easley KA, et al. Postmortem cardiomegaly and echocardiographic measurements of left ventricular size and function in children infected with the human immunodeficiency virus. The Prospective P2C2 HIV Multicenter Study. Cardiovasc Pathol 2003;12:140-8.

Fisher SD, Bowles NE, Towbin JA, Lipshultz SE. Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genes. AIDS 2003;17 Suppl 1:S29-35.

Sanchez-Torres RJ, Garcia-Palmieri MR. Cardiovascular disease in HIV infection. P R Health Sci J 2006;25:249-54.

Sudano I, Spieker LE, Noll G, Corti R, Weber R, Luscher TF. Cardiovascular disease in HIV infection. Am Heart J 2006;151:1147-55.

Barbaro G. Pathogenesis of HIV-associated heart disease. AIDS 2003;17 Suppl 1:S12-20.

Al-Attar I, Orav EJ, Exil V, Vlach SA, Lipshultz SE. Predictors of cardiac morbidity and related mortality in children with acquired immunodeficiency syndrome. J Am Coll Cardiol 2003;41:1598-605.

Breuckmann F, Neumann T, Kondratieva J, et al. Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART). Eur J Med Res 2005;10:395-9.

Barry Greenberg AMK. Clinical Assessment of Heart Failure. In: Robert O Bonow DLM, Douglas P Zipes, Peter Libby, ed. Braundwald's Heart Disease A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia: Elsevier Saunders; 2012:505-6.

Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.

McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012.

Kansal P, Montpetit MC, O'Connell JB. Heart Failure and Cardiomyopathy: Dilated Cardiomyopathy. In: Crawford MH, DiMarco JP, Paulus WJ, eds. Cardiology. 3rd ed. Philadelphia: Mosby Elsevier; 2010:1079-83.

Lipshultz SE, Fisher SD, Lai WW, Miller TL. Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS 2003;17 Suppl 1:S96-122.

Restrepo CS, Diethelm L, Lemos JA, et al. Cardiovascular complications of human immunodeficiency virus infection. Radiographics 2006;26:213-31.

Anderson L, Pennell D. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Eur Heart J 2008;29:1696; author reply -7.

Lipshultz SE, Orav EJ, Sanders SP, Colan SD. Immunoglobulins and left ventricular structure and function in pediatric HIV infection. Circulation 1995;92:2220-5.

Ho JE, Hsue PY. Cardiovascular manifestations of HIV infection. Heart 2009;95:1193-202.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 YARSI Medical Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

__________________________________________________________________________________________

Copyright of YARSI Medical Journal.

Powered by OJS.

Creative Commons License

This work is licensed under a Creative Commons Attribution- NonCommercial 4.0 International License.